VeriMomIst potassium phenylbenzimidazole sulfonate in der Schwangerschaft sicher?
Potassium phenylbenzimidazole sulfonate (the water‑soluble salt of phenylbenzimidazole sulfonic acid, INCI often reported as Phenylbenzimidazole Sulfonic Acid/its salts) is a UVB filter with no harmonised reproductive classification and no convincing animal or human reproductive/toxic endocrine data in regulatory reviews; CIR/SCCS assessments do not identify reproductive hazard. Dermal absorption is low but measurable for this class of water‑soluble UV filters, so exposure in pregnancy is low but not zero (SCCS/CosIng/PubChem summaries).
Related ingredients
Frequently asked questions
- Ist potassium phenylbenzimidazole sulfonate in der Schwangerschaft sicher?
- Potassium phenylbenzimidazole sulfonate (the water‑soluble salt of phenylbenzimidazole sulfonic acid, INCI often reported as Phenylbenzimidazole Sulfonic Acid/its salts) is a UVB filter with no harmonised reproductive classification and no convincing animal or human reproductive/toxic endocrine data in regulatory reviews; CIR/SCCS assessments do not identify reproductive hazard. Dermal absorption is low but measurable for this class of water‑soluble UV filters, so exposure in pregnancy is low but not zero (SCCS/CosIng/PubChem summaries).
- Ist potassium phenylbenzimidazole sulfonate während des Stillens sicher?
- Same rationale as for pregnancy: no regulatory harmonised reproductive or lactation hazard identified and no mechanistic evidence for transfer into milk in available safety assessments; dermal exposure is low but measurable, so postpartum topical use implies low maternal systemic exposure and therefore low likelihood of meaningful transfer into breast milk (SCCS/CosIng/PubChem).
- Ist potassium phenylbenzimidazole sulfonate sicher für Babyhaut?
- No infant‑specific reproductive or developmental hazards reported; however, due to immature infant barrier and higher surface‑area‑to‑body‑weight, measurable dermal absorption of this water‑soluble UV filter warrants increasing exposure score for 0–3 year skin to moderate. Regulatory safety reviews (SCCS/CosIng) do not flag developmental or endocrine concerns but note exposure considerations for application to young children.
- Wie bewertet VeriMom potassium phenylbenzimidazole sulfonate?
- VeriMom bewertet potassium phenylbenzimidazole sulfonate mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu potassium phenylbenzimidazole sulfonate?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu potassium phenylbenzimidazole sulfonate basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.